First Header Logo Second Header Logo

Connection

Thomas Wierzba to Shigella

This is a "connection" page, showing publications Thomas Wierzba has written about Shigella.
Connection Strength

1.182
  1. Barry E, Cassels F, Riddle M, Walker R, Wierzba T. Vaccines Against Shigella and Enterotoxigenic Escherichia coli: A summary of the 2018 VASE Conference. Vaccine. 2019 08 07; 37(34):4768-4774.
    View in: PubMed
    Score: 0.819
  2. Wierzba TF. Implications and measurement of herd protection (indirect effects) for enteric vaccine development. Vaccine. 2019 08 07; 37(34):4775-4777.
    View in: PubMed
    Score: 0.205
  3. Abu-Elyazeed RR, Wierzba TF, Frenck RW, Putnam SD, Rao MR, Savarino SJ, Kamal KA, Peruski LF, Abd-El Messih IA, El-Alkamy SA, Naficy AB, Clemens JD. Epidemiology of Shigella-associated diarrhea in rural Egyptian children. Am J Trop Med Hyg. 2004 Sep; 71(3):367-72.
    View in: PubMed
    Score: 0.073
  4. Walker RI, Wierzba TF, Mani S, Bourgeois AL. Vaccines against Shigella and enterotoxigenic Escherichia coli: A summary of the 2016 VASE Conference. Vaccine. 2017 12 14; 35(49 Pt A):6775-6782.
    View in: PubMed
    Score: 0.045
  5. Mani S, Wierzba T, Walker RI. Status of vaccine research and development for Shigella. Vaccine. 2016 06 03; 34(26):2887-2894.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.